First interferon for the product InterferOX is manufactured
FarmPharma AB, which is a subsidiary of Double Bond Pharmaceutical AB, today reported that the first recombinant bovine interferon, which is the first component of FarmPharma’s product InterferOX, was manufactured.
“The development of antiviral agents with innovative mechanisms of action is becoming more and more current,” comments Igor Lokot, SO of FarmPharma, – We are very pleased that with the manufacture of the first interferon network we have achieved an important milestone in the development of InterferOX.
More about FarmPharma: FarmPharma AB is a subsidiary of Double Bond Pharmaceutical. The company operates in the development and distribution of veterinary products, and their first product is for the prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics.